668
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Biodistribution of TNF-α-Coated Gold Nanoparticles in An In Vivo Model System

, , , &
Pages 401-410 | Published online: 08 Jun 2009

Bibliography

  • Ferrari M : Cancer nanotechnology: opportunities and challenges.Nat. Rev. Cancer5, 161–171 (2005).
  • Cuenca AG , JiangH, HochwaldSN, DelanoM, CanceWG, GrobmyerSR: Emerging implications of nanotechnology on cancer diagnostics and therapeutics.Cancer107, 459–466 (2006).
  • Yezhelyev MV , GaoX, XingY, Al-HajjA, NieS, O‘ReganRM: Emerging use of nanoparticles in diagnosis and treatment of breast cancer.Lancet Oncol.7, 657–667 (2006).
  • Paciotti GF , MyerL, WeinreichDet al.: Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery.Drug Deliv.11, 169–183 (2004).
  • Farma JM , PuhlmannM, SorianoPAet al.: Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factor.Int. J. Cancer120, 2474–2480 (2007).
  • Goel R , SwanlundD, CoadJ, PaciottiGF, BischofJC: TNF-α-based accentuation in cryoinjury – dose, delivery, and response.Mol. Cancer Ther.6, 2039–2047 (2007).
  • Visaria R , BischofJC, LorenMet al.: Nanotherapeutics for enhancing thermal therapy of cancer.Int. J. Hyperthermia23, 501–511 (2007).
  • Visaria RK , GriffinRJ, WilliamsBWet al.: Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-α delivery.Mol. Cancer Ther.5, 1014–1020 (2006).
  • Chithrani BD , ChanWC: Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes.Nano Lett.7, 1542–1550 (2007).
  • Chithrani BD , GhazaniAA, ChanWC: Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.Nano Lett.6, 662–668 (2006).
  • Dobrovolskaia MA , McNeilSE: Immunological properties of engineered nanomaterials.Nat. Nanotechnol.2, 469–478 (2007).
  • Dobrovolskaia MA , PatriAK, ZhengJet al.: Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.Nanomedicine5(2), 106–117 (2009).
  • Dobrovolskaia MA , AggarwalP, HallJB, McNeilSE: Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.Mol. Pharm.5, 487–495 (2008).
  • Cai QY , KimSH, ChoiKSet al.: Colloidal gold nanoparticles as a blood-pool contrast agent for X-ray computed tomography in mice.Invest. Radiol.42, 797–806 (2007).
  • de Jong WH , HagensWI, KrystekP, BurgerMC, SipsAJ, GeertsmaRE: Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.Biomaterials29, 1912–1919 (2008).
  • Hillyer JF , AlbrechtRM: Correlative instrumental neutron activation analysis, light microscopy, transmission electron microscopy, and x-ray microanalysis for qualitative and quantitative detection of colloidal gold spheres in biological specimens.Microsc. Microanal.4, 481–490 (1998).
  • Niidome T , YamagataM, OkamotoYet al.: PEG-modified gold nanorods with a stealth character for in vivo applications.J. Control Release114, 343–347 (2006).
  • Renaud G , HamiltonRL, HavelRJ: Hepatic metabolism of colloidal gold-low-density lipoprotein complexes in the rat: evidence for bulk excretion of lysosomal contents into bile.Hepatology9, 380–392 (1989).
  • Hardonk MJ , HarmsG, KoudstaalJ: Zonal heterogeneity of rat hepatocytes in the in vivo uptake of 17 nm colloidal gold granules.Histochemistry83, 473–477 (1985).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.